Related references
Note: Only part of the references are listed.Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Carlos A. DiazGranados et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cochrane re-arranged: Support for policies to vaccinate elderly people against influenza
Walter E. P. Beyer et al.
VACCINE (2013)
High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009-2010 season
Carlos A. DiazGranados et al.
VACCINE (2013)
Postlicensure Safety Surveillance for High-Dose Trivalent Inactivated Influenza Vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010
Pedro L. Moro et al.
CLINICAL INFECTIOUS DISEASES (2012)
Lessons learned from an osteoporosis clinical trial in frail long-term care residents
S. L. Greenspan et al.
CLINICAL TRIALS (2012)
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59® adjuvant Results from a dose-finding clinical trial in older adults
Giovanni Della Cioppa et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Inactivated Influenza Vaccines Recent Progress and Implications for the Elderly
Valentina Parodi et al.
DRUGS & AGING (2011)
Gait Speed and Survival in Older Adults
Stephanie Studenski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection
Suzanne E. Ohmit et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine
Wilbur H. Chen et al.
VACCINE (2011)
Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine
Seth J. Sullivan et al.
EXPERT REVIEW OF VACCINES (2010)
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force
Gabor Abellan Van Kan et al.
Journal of Nutrition Health & Aging (2010)
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects
Thomas R. Cate et al.
VACCINE (2010)
Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence
Joon Young Song et al.
VACCINE (2010)
Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older
Ann R. Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
Iain Stephenson et al.
EMERGING INFECTIOUS DISEASES (2009)
Immunosenescence and vaccine failure in the elderly
Beatrix Grubeck-Loebenstein et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Rapid decline of influenza vaccine-induced antibody in the elderly: Is it real, or is it relevant?
Danuta M. Skowronski et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
Robert B. Couch et al.
VACCINE (2007)
Efficacy of a hip protector to prevent hip fracture in nursing home residents - The HIPPRO randomized controlled trial
Douglas P. Kiel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Emerging respiratory viruses: Challenges and vaccine strategies
Laura Gillim-Ross et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia - A randomized controlled trial
Mark Loeb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons
Wendy A. Keitel et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults
JJ Treanor et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States
RA Bright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Antibody response to influenza vaccination in the elderly: A quantitative review
K Goodwin et al.
VACCINE (2006)
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
RA Bright et al.
LANCET (2005)
The unmet need in the elderly: Designing new influenza vaccines for older adults
JE McElhaney
VACCINE (2005)
Impact of glycosylation on the immunogenicity of a DNA-based influenza H5HA vaccine
RA Bright et al.
VIROLOGY (2003)
Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins
JA Mitchell et al.
VACCINE (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge
TM Ross et al.
NATURE IMMUNOLOGY (2000)
Share Paper
